Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-17

Clinical Trial Update: Effectiveness of and Implementation Strategies for 'Disfrutando'. [NA]

View source ↗

Summary

A planned clinical trial led by University of Missouri-Columbia evaluating the effectiveness and implementation strategies of Disfrutando for Type 2 Diabetes Me…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Disfrutando

Snippet

Sponsor: University of Missouri-Columbia | Conditions: Type 2 Diabetes Mellitus (T2DM) | NA | Status: NOT_YET_RECRUITING